bijoy2526

AUROPHARMA taking support on monthly trend line and 20 dma

Long
NSE:AUROPHARMA   AUROBINDO PHARMA
its attempt to cross target 1 getting rejected.
with no negative news
if crosses target 1 target 2 and target 3
possible.
Comment: usa decision to reduce drug prices may have negative impact.
little bad news for pharma companies.